Microsoft Corporation vs F. Hoffmann-La Roche AG: Strategic Comparison
Key Differences at a Glance
| Field | Microsoft Corporation | F. Hoffmann-La Roche AG |
|---|---|---|
| Revenue | $281.7B | $77.2B |
| Founded | 1975 | 1896 |
| Employees | 228,000 | 112,774 |
| Market Cap | $2.96T | $327.5B |
| Headquarters | United States | Switzerland |
Quick Stats Comparison
| Metric | Microsoft Corporation | F. Hoffmann-La Roche AG |
|---|---|---|
| Revenue | $281.7B | $77.2B |
| Founded | 1975 | 1896 |
| Headquarters | Redmond, Washington, United States | Basel, Switzerland |
| Market Cap | $2.96T | $327.5B |
| Employees | 228,000 | 112,774 |
Microsoft Corporation Revenue vs F. Hoffmann-La Roche AG Revenue — Year by Year
| Year | Microsoft Corporation | F. Hoffmann-La Roche AG | Leader |
|---|---|---|---|
| 2025 | $281.7B | $77.2B | Microsoft Corporation |
| 2024 | $245.1B | $75.9B | Microsoft Corporation |
| 2023 | $211.9B | $75.9B | Microsoft Corporation |
Business Model Breakdown
Overview: Microsoft Corporation vs F. Hoffmann-La Roche AG
This in-depth comparison examines Microsoft Corporation and F. Hoffmann-La Roche AG across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Microsoft Corporation on its own, evaluating F. Hoffmann-La Roche AG, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Microsoft Corporation and F. Hoffmann-La Roche AG is widest.
On the headline numbers, Microsoft Corporation reports annual revenue of $281.7B against $77.2B for F. Hoffmann-La Roche AG, while their respective market capitalizations stand at $2.96T and $327.5B. Microsoft Corporation is headquartered in United States and F. Hoffmann-La Roche AG operates from Switzerland, and those different home markets shape how each company competes.
Microsoft Corporation: Microsoft Corporation is a public company listed on NASDAQ under ticker MSFT. Microsoft makes money from cloud infrastructure, enterprise and consumer subscriptions, software licenses, Windows OEM and commercial licensing, LinkedIn, search and advertising, devices, gaming content, and developer platforms.
F. Hoffmann-La Roche AG: Roche is not just a drug company with a diagnostics side business. Its strategic identity is an integrated healthcare model: test the patient, identify the biology, treat with a targeted therapy, and use outcome data to improve the next development cycle.
Business Models: How Microsoft Corporation and F. Hoffmann-La Roche AG Make Money
Microsoft Corporation and F. Hoffmann-La Roche AG pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Microsoft Corporation and F. Hoffmann-La Roche AG.
Microsoft Corporation business model: Microsoft makes money from cloud infrastructure, enterprise and consumer subscriptions, software licenses, Windows OEM and commercial licensing, LinkedIn, search and advertising, devices, gaming content, and developer platforms.
F. Hoffmann-La Roche AG business model: Roche makes money from branded prescription medicines, biologics, oncology and specialty drugs, diagnostic instruments, diagnostic reagents, sequencing and molecular testing, diabetes care products, and clinical data assets. Pharmaceuticals drive the largest share of sales, while Diagnostics adds recurring reagent revenue and supports personalized healthcare.
Competitive Advantage: Microsoft Corporation vs F. Hoffmann-La Roche AG
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Microsoft Corporation stack up against those of F. Hoffmann-La Roche AG.
Microsoft Corporation competitive advantage: Microsoft's advantage is enterprise distribution, Azure scale, Office workflows, Windows reach, developer tools, security products, LinkedIn, GitHub, and deep AI partnerships.
F. Hoffmann-La Roche AG competitive advantage: Roche's advantage is the combination of drug development, diagnostics, Genentech biotechnology depth, companion diagnostic capability, and oncology data assets from Foundation Medicine and Flatiron Health. Competitors can match pieces of this model, but few can connect medicines, tests, and real-world data at similar scale.
Growth Strategy: Where Microsoft Corporation and F. Hoffmann-La Roche AG Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Microsoft Corporation and F. Hoffmann-La Roche AG each plan to expand from here.
Microsoft Corporation growth strategy: Microsoft Corporation's growth strategy centers on this advantage: Microsoft's advantage is enterprise distribution, Azure scale, Office workflows, Windows reach, developer tools, security products, LinkedIn, GitHub, and deep AI partnerships.
F. Hoffmann-La Roche AG growth strategy: Roche is investing in late-stage medicines, diagnostics platforms, sequencing, companion diagnostics, real-world evidence, and selective acquisitions that strengthen oncology, immunology, neuroscience, and cardiovascular-metabolic disease areas.
Financial Picture: Microsoft Corporation vs F. Hoffmann-La Roche AG
A closer look at the financial trajectory of Microsoft Corporation and F. Hoffmann-La Roche AG rounds out the comparison.
Microsoft Corporation: Microsoft Corporation reported FY2025 revenue of $281.724B and net income of $101.832B.
F. Hoffmann-La Roche AG: Roche reported CHF 61.5 billion in 2025 group sales. Pharmaceuticals sales were CHF 47.7 billion and Diagnostics sales were CHF 13.8 billion. Core operating profit was CHF 21.8 billion, and R&D core investments were CHF 12.2 billion. For USD comparability, this profile converts CHF 61.5 billion at 1 CHF = 1.25506 USD.
Company-Specific SWOT Notes
Microsoft Corporation
Microsoft already sits inside enterprise identity, productivity, cloud, security, developer, and operating-system workflows.
AI and cloud capacity require large capital spending before every workload proves its long-term margin profile.
Copilots, Azure AI, GitHub, security, and business applications can turn installed-base reach into new recurring revenue.
Antitrust scrutiny, security incidents, hyperscaler competition, and platform shifts can slow growth or raise costs.
F. Hoffmann-La Roche AG
Roche's advantage is the combination of drug development, diagnostics, Genentech biotechnology depth, companion diagnostic capability, and oncology data assets from Foundation Medicine and Flatiron Health.
Roche wins by combining medicines, diagnostics, biomarkers, and oncology data into a precision-healthcare model competitors struggle to copy.
The biggest risk is that biosimilar erosion and pricing pressure outrun the replacement power of Roche new launches and late-stage pipeline.
Roche is investing in late-stage medicines, diagnostics platforms, sequencing, companion diagnostics, real-world evidence, and selective acquisitions that strengthen oncology, immunology, neuroscience, and cardiovascular-metabolic disease areas.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Microsoft Corporation | Microsoft Corporation reports the larger revenue base ($281.7B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | F. Hoffmann-La Roche AG | Founded in 1975 vs 1896. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Microsoft Corporation | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Microsoft Corporation | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Microsoft Corporation | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Microsoft Corporation reports the larger revenue base ($281.7B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1975 vs 1896. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Microsoft Corporation or F. Hoffmann-La Roche AG?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Microsoft Corporation vs F. Hoffmann-La Roche AG
Is Microsoft Corporation better than F. Hoffmann-La Roche AG?
Verdict: Between Microsoft Corporation and F. Hoffmann-La Roche AG, Microsoft Corporation is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Microsoft Corporation comes out ahead in this Microsoft Corporation vs F. Hoffmann-La Roche AG comparison.
Who earns more — Microsoft Corporation or F. Hoffmann-La Roche AG?
Microsoft Corporation earns more with $281.7B in annual revenue versus F. Hoffmann-La Roche AG's $77.2B. Microsoft Corporation leads on total revenue based on latest verified figures.
Which company has higher revenue — Microsoft Corporation or F. Hoffmann-La Roche AG?
Microsoft Corporation reported $281.7B, while F. Hoffmann-La Roche AG reported $77.2B. The revenue leader is Microsoft Corporation based on latest verified figures.
Microsoft Corporation revenue vs F. Hoffmann-La Roche AG revenue — which is higher?
Microsoft Corporation revenue: $281.7B. F. Hoffmann-La Roche AG revenue: $77.2B. Microsoft Corporation has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Microsoft Corporation Annual Filings (10-K, 8-K)
- Microsoft Corporation Corporate Website
- Microsoft Corporation Annual Report 2025 - Revenue and Financial Data
- sec.gov
- microsoft.com
- microsoft.com
- learn.microsoft.com
- news.microsoft.com
- blogs.microsoft.com
- F. Hoffmann-La Roche AG Corporate Website
- F. Hoffmann-La Roche AG Annual Report 2025 - Revenue and Financial Data
- roche.com
- roche.com
- assets.roche.com
- roche.com
- stockanalysis.com
- ofx.com